Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhanced Recovery Versus Standard Recovery After Low-risk Pancreatoduodenectomy Identified With Acinar Cell Count or Total Pancreatectomy: a Randomized Controlled Trial

NCT03757455 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT03757455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03757455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhanced Recovery Versus Standard Recovery After Low-risk Pancreatoduodenectomy Identified With Acinar Cell Count or Total Pancreatectomy: a Randomized Controlled Trial
Lead sponsor
Tampere University Hospital
Phase
Not applicable
Overall status
Terminated
Start date
September 1, 2020
Completion date
October 1, 2021
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delayed gastric emptying, pancreatic cancer, pancreatic fistula, pancreatic hemorrhage, surgery--complications